AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer—a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI)

Autor: D. Ferastraoaru, H. J. Bax, C. Bergmann, M. Capron, M. Castells, D. Dombrowicz, E. Fiebiger, H. J. Gould, K. Hartmann, U. Jappe, G. Jordakieva, D. H. Josephs, F. Levi-Schaffer, V. Mahler, A. Poli, D. Rosenstreich, F. Roth-Walter, M. Shamji, E. H. Steveling-Klein, M. C. Turner, E. Untersmayr, S. N. Karagiannis, E. Jensen-Jarolim

Publikováno v: Clinical and Translational Allergy, Vol 10, Iss 1, Pp 1-16 (2020)

Abstract Elevated serum IgE levels are associated with allergic disorders, parasitosis and specific immunologic abnormalities. In addition, epidemiological and mechanistic evidence indicates an association between IgE-mediated immune surveillance and

Externí odkaz: https://doaj.org/article/36a0b020323b456eaa5ab6efccfb84e4

Kleine Ursache – große Wirkung: Spättyp-Hauttests mit Medikamenten als Auslöser von disseminierten Rezidivexanthemen

Autor: Andreas J. Bircher, Dagmar Jamiolkowski, Esther H. Steveling-Klein, Kathrin Scherer Hofmeier, Carlos Morales Mateluna

Publikováno v: Aktuelle Dermatologie. 48:260-266

ZusammenfassungEs werden zwei Patienten vorgestellt, die wegen eines streuenden allergischen Kontakt- bzw. Arzneimittelexanthems auf Budesonid bzw. Antibiotika abgeklärt wurden. Bei beiden trat innerhalb einiger Stunden nach Anlegen eines Epikutante

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7c2fe10c3438eea9daf73740e68f75f8
https://doi.org/10.1055/a-1539-2221

Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response

Autor: Mongkol Lao-araya, Stephen R. Durham, Oliver Hunewald, Anke-Hilse Maitland-van der Zee, Balthasar A. Heesters, Janice A. Layhadi, Gemma Vilà-Nadal, Korneliusz Golebski, Esther H. Steveling-Klein, Mohamed H. Shamji, Rachael C.Y. Li, Suzanne M. Bal, Wytske Fokkens, Cornelis M. van Drunen, Feng He, Umit Murat Sahiner, Susanne J. H. Vijverberg, Markus Ollert, Oleksandra Fedina, Madison M. Lenormand, Hergen Spits, Guillem Montamat

Publikováno v: Immunity, 54(2), 291-307.e7. Cell Press
Immunity, 54(2), 291. Cell Press
307.e7
Golebski, K, Layhadi, J A, Sahiner, U, Steveling-Klein, E H, Lenormand, M M, Li, R C Y, Bal, S M, Heesters, B A, Vilà-Nadal, G, Hunewald, O, Montamat, G, He, F Q, Ollert, M, Fedina, O, Lao-Araya, M, Vijverberg, S J H, Maitland-van der Zee, A H, van Drunen, C M, Fokkens, W J, Durham, S R, Spits, H & Shamji, M H 2021, ' Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response ', Immunity, vol. 54, no. 2, pp. 291-307.e7 . https://doi.org/10.1016/j.immuni.2020.12.013

The role of innate immune cells in allergen immunotherapy that confers immune tolerance to the sensitizing allergen is unclear. Here, we report a role of interleukin-10-producing type 2 innate lymphoid cells (IL-10+ ILC2s) in modulating grass-pollen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::622c6c31bcc0f5cbd5b2bdf9848d4676
https://pure.amc.nl/en/publications/induction-of-il10producing-type-2-innate-lymphoid-cells-by-allergen-immunotherapy-is-associated-with-clinical-response(229380d1-a168-41ca-a2cf-67cf7a6c8968).html

Einfluss der endoskopischen Lungenvolumenreduktion mit Ventilen auf den pulmonalen Gasaustausch

Autor: R Karpf-Wissel, Kaid Darwiche, H Steveling, H Hautzel, K Stiehl, J Winantea, Christian Taube

Publikováno v: 60. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V..

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7f5512c1df8bd3fa1fc3f8ba46be2ac6
https://doi.org/10.1055/s-0039-1677969

Alpha-1-Antitrypsin-Mangel: Update

Autor: H. Steveling, J. Hamacher, G. Steinkamp, C. Vogelmeier

Publikováno v: Pneumologie. 63:718-725

The time delay between the start of respiratory symptoms and the correct diagnosis of alpha-1-antitrypsin (AAT) deficiency is often 6 to 8 years. Most patients are misdiagnosed as having COPD or asthma. Recent estimates suggest that only 15 % of pati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8e14d2aaf358799da23799f65a819a67
https://doi.org/10.1055/s-0029-1215207